Abstract
With an aim to develop a sensitive immunoassay for ovarian cancer detection that has linearity over a broad range, we hereby report a dual gold nanostructure-based electrochemical immunosensor to detect ovarian cancer biomarker carcinoma antigen 125 (CA125) in serum. Gold nanorods (GNRs) are coated on indium tin oxide (ITO) and used as working electrode after immobilizing capture anti-CA125 on it. Second, gold nanoparticles (GNPs) tagged with cadmium ion (Cd2+) and another CA125 antibody is used as a probe for signal generation. A sandwich between gold nanorod-modified working electrode and GNP-based probe is formed through CA125 antigen. Direct detection of probe bound on the surface of immunosensor was done by differential pulse voltammetry (DPV) and the peak signals were directly proportional to the CA125 antigen concentration. The developed sensor has shown a detection limit of 3.4 U mL−1 with a broad linear detection range of 20–100 U mL−1. The immunosensor is stable, reproducible and has a good correlation coefficient of 0.97 for the clinical serum samples tested with the developed immunosensor and enzyme-linked immunosorbent assay (ELISA). It has the potential to detect CA125 in clinical samples which show abnormally high or low levels of CA125 in serum.
Similar content being viewed by others
References
Basu P, De P, Mandal S, Ray K, Biswas J (2009) Study of ‘patterns of care’ of ovarian cancer patients in a specialized cancer institute in Kolkata, eastern India. Indian J Cancer 46:28¬–33
Chen X, Ma Z (2014) Multiplexed electrochemical immunoassay of biomarkers using chitosan nanocomposites. Biosens Bioelectron 55:343–349
Chen S, Yuan R, Chai Y, Min L, Li W, Xu Y (2009) Electrochemical sensing platform based on tris (2,2′-bipyridyl) cobalt(III) and multiwall carbon nanotubes-Nafion composite for immunoassay of carcinoma antigen-125. Electrochim Acta 54:7242–7247
Chikkaveeraiah BV, Mani V, Patel V, Gutkind JS, Rusling JF (2011) Microfluidic electrochemical immunoarray for ultrasensitive detection of two cancer biomarker proteins in serum. Biosens Bioelectron 26:4477–4483
Freedland SJ (2011) Screening, risk assessment and the approach to therapy in patients with prostate cancer. Cancer 117:1123–1135
Gong Z, Karandikar S, Zhang X, Kotipalli V, Lvov Y, Que L (2010) Composite nanomaterial thin film-based biosensors. In: Sensors 2010 IEEE Sensors pp. 29–32
Guo Z, Hao T, Du S, Chen B, Wang Z, Li X, Wang S (2013) Multiplex electrochemiluminescence immunoassay of two tumor markers using multicolor quantum dots as labels and graphene as conducting bridge. Biosens Bioelectron 44:101–107
He ZH, Gao N, Jin WR (2003) Determination of tumor marker CA125 by capillary electrophoretic enzyme immunoassay with electrochemical Detection. Anal Chim Acta 497:75–81
Jia X, Liu Z, Liu N, Ma Z (2014) A label-free immunosensor based on graphene nanocomposites for simultaneous multiplexed electrochemical determination of tumor markers. Biosens Bioelectron 53:160–166
Jicha DC (1962) Complexes Derived from Strong Field Ligands. XIII. Complexes of b-Mercaptoethylamine with Nickel(II), Palladium(II), Cobalt(PI). Inorg Chem 1:872–877
Jin L, Li J, Liu L, Wang Z, Zhang X (2018) Facile synthesis of carbon dots with superior sensing ability. Appl Nanosci 8:1189–1196
Johari-Ahar M, Rashidi MR, Barar J, Aghaie M, Mohammadnejad D, Ramazani A, Karami P, Coukos G, Omidi Y (2015) An ultra-sensitive impedimetric immunosensor for detection of serum oncomarker CA-125 in ovarian cancer patients. Nanoscale 7:376–879
Kang JO, Hudak WA, Keller N (1988) Enzyme-linked immunosorbent assay of CA-125 in serum of patients with endometriosis: efficacy in diagnosis. Clin Chem 34:1983–1986
Klapková E, Průša R, Kukačka J, Kotaška K, Škapa Klin P (2007) Unexpected high serum level of CA 125 in male patient suffering from metastatic papillary carcinoma: a case report. Biochem Metab 15:155–156
Li X, Wu X, Ni Y (1996) Clinical determination of tumor markers. People’s Healthy Press, Beijing
Lin J, Wei Z, Mao C (2011) A label-free immunosensor based on modified mesoporous silica for simultaneous determination of tumor markers. Biosens Bioelectron 29:40–45
Nikoobakht B, Sayed AE (2003) Preparation and growth mechanism of gold nanorods (NRs) using seed—mediated growth method. Chem Mater 16:1957–1962
Niu Y, Stadler FJ, He T, Zhang X, Yu Y, Chen S (2017) Smart multifunctional polyurethane microcapsules for the quick release of anticancer drugs in BGC 823 and HeLa tumor cells. J Mater Chem B 5(48):9477–9481
Parekh G, Shi Y, Zheng J, Zhang X, Leporatti S (2018) Nano-carriers for targeted delivery and biomedical imaging enhancement. Ther Deliv 9(6):451–468
Rasooly A, Jacobson J (2006) Development of biosensors for cancer clinical testing. Biosens Bioelectron 21:1851–1858
Ravalli A, Pilon Dos Santos G, Ferroni M, Faglia G, Yamanaka H, Marrazza G (2013) New label free CA125 detection based on gold nanostructured screen-printed electrode. Sens Actuator B-Chem 179:194–200
Reinsberg J, Schultes B, Wagner U, Krebs D (1993) Monitoring cancer antigen 125 in serum of ovarian cancer patients after administration of 131I-labeled F(ab’)2 fragments of OC125 antibody. Clin Chem 39:891–896
Ren X, Wang H, Wu D, Fan D, Zhang Y, Du B, Wei Q (2015) Ultrasensitive immunoassay for CA125 detection using acid site compound as signal and enhancer. Talanta 144:535–541
Rubin J, Rockey DC (1999) Cirrhotic ascites, ovarian carcinoma, and CA-125. South Med J 92:248–250
Ryder KW, Oei TO, Hull MT, Sample MM (1988) An enzyme immunoassay procedure for cancer antigen 125 evaluated. Clin Chem 34:2513–2516
Singh J, Sharma S, Nara S (2015) Evaluation of gold nanoparticle based lateral flow assays for diagnosis of enterobacteriaceae members in food and water. Food Chem 170:470–483
Tang D, Yuan R, Chai Y (2006) Electrochemical immuno-bioanalysis for carcinoma antigen 125 based on thionine and gold nanoparticles-modified carbon paste interface. Anal Chim Acta 564:158–165
Torati SR, Kasturi KCSB, Lim B, Kim C (2017) Hierarchical gold nanostructures modified electrode for electrochemical detection of cancer antigen CA125. Sensors Actuators B Chem 243:64–71
Vergara D, Bellomo C, Zhang X, Vergaro V, Tinelli A, Lorusso V, Rinaldi R, Lvov YM, Leporatti S, Maffia M (2012) Lapatinib/paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer. Nanomed NBM 8(6):891–899
Vergaro V, Scarlino F, Bellomo C, Rinaldi R, Vergara D, Maffia M, Baldassarre F, Giannelli G, Zhang X, Lvov YM, Leporatti S (2011) Drug-loaded polyelectrolyte microcapsules for sustained targeting of cancer cells. Adv Drug Deliv Rev 63(9):847–864
Wang Z, Liu N, Ma Z (2014) Platinum porous nanoparticles hybrid with metal ions as probes for simultaneous detection of multiplex cancer biomarkers. Biosens Bioelectron 53:324–329
Wickstrom M, Larsson R, Nygren P, Gullbo J (2011) Aminopeptidase N (CD13) as a Target for Cancer Chemotherapy. Cancer Sci 102:501–508
Wu JT, Miya T, Knight JA, Knight DP (1988) Improved specificity of the CA 125 enzyme immunoassay for ovarian carcinomas by use of the ratio of CA 125 to carcinoembryonic antigen. Clin Chem 34:1853–1857
Wu L, Chen J, Du D, Ju H (2006) Electrochemical immunoassay for CA125 based on cellulose acetate stabilized antigen/colloidal gold nanoparticles membrane. Electrochim Acta 51:1208–1214
Wu L, Yan F, Ju H (2007) An amperometric immunosensor for separation-free immunoassay of CA125 based on its covalent immobilization coupled with thionine on carbon nanofiber. J Immunol Methods 322:12–19
Wu L, Sha Y, Li W, Wang V, Guo Z, Zhou J, Su X, Jiang X (2016) One-step preparation of disposable multi-functionalized g-C3N4 based electrochemiluminescence immunosensor for the detection of CA125. Sensors Actuators B Chem 226:62–68
Xu T, Jia X, Chen X, Ma Z (2014) Simultaneous electrochemical detection of multiple tumor markers using metal ions tagged immunocolloidal gold. Biosens Bioelectron 56:174–179
Yang Y, Jin P, Zhang X, Ravichandran N, Ying H, Yu C, Ying H, Xu Y, Yin J, Wang K, Wu M (2017) New epigallocatechin gallate (EGCG) nanocomplexes co-assembled with 3-mercapto-1-hexanol and β-lactoglobulin for improvement of antitumor activity. J Biomed Nanotechnol 13(7):805–814
Zhou C, Liu D, Xu L. Li Q, Song J, Xu S, Xing R, Song H (2015) A sensitive label–free amperometric immunosensor for alpha-fetoprotein based on gold nanorods with different aspect ratio. Sci Rep 5:1–7
Acknowledgements
We gratefully acknowledge Director of MNNIT Allahabad for providing necessary research facilities, Sophisticated Analysis Instrumentation Facility, Panjab University, Chandigarh for TEM facility, Centre for Interdisciplinary Research (CIR), MNNIT, Allahabad for electrochemical workstation facility and Design and Innovation Centre (DIC), Ministry of Human Resource and Development (MHRD), New Delhi for their kind support. The authors also thank sincerely to Dr. Manisha Sachan, Assistant Professor, Department of Biotechnology, MNNIT Allahabad and Kings George Medical University (KGMU, Lucknow, India) for their generous effort in providing serum samples of ovarian cancer patients.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors have no conflict of interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kumar, N., Sharma, S. & Nara, S. Dual gold nanostructure-based electrochemical immunosensor for CA125 detection. Appl Nanosci 8, 1843–1853 (2018). https://doi.org/10.1007/s13204-018-0857-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13204-018-0857-y